Shinya Katsutani

A lower starting dose of eltrombopag is efficacious in Japanese patients with previously treated chronic immune thrombocytopenia

Yoshiaki Tomiyama, Yoshitaka Miyakawa, Shinichiro Okamoto et al. · Journal of Thrombosis and Haemostasis · 2012 · 99 citations · Full text

Thrombopoiesis, Thrombosis, Venous Thrombosis +12

Efficacy and safety of the neonatal Fc receptor inhibitor efgartigimod in adults with primary immune thrombocytopenia (ADVANCE IV): a multicentre, randomised, placebo-controlled, phase 3 trial

Catherine M. Broome, Vickie McDonald, Yoshitaka Miyakawa et al. · The Lancet · 2023 · 77 citations · Full text

Thrombopoiesis, Autoimmune Disease, Blood Platelet +11

Thrombospondin-bound Integrin-associated Protein (CD47) Physically and Functionally Modifies Integrin αIIbβ3 by Its Extracellular Domain

Tetsuro‐Takahiro Fujimoto, Shinya Katsutani, Takeshi Shimomura et al. · Journal of Biological Chemistry · 2003 · 48 citations · Full text

A point mutation in glycoprotein IX coding sequence (Cys73 (TGT) to Tyr(TAT)) causes impaired surface expression of GPIb/IX/V complex in two families with Bernard-Soulier syndrome.

Masaaki Noda, Kingo Fujimura, Toshiro Takafuta et al. · PubMed · 1996 · 45 citations

Transcriptional Regulation, Systems Biology, Engineering +15

Oligoclonal accumulation of T cells in peripheral blood from patients with idiopathic thrombocytopenic purpura

Takeshi Shimomura, Kingo Fujimura, Toshiro Takafuta et al. · British Journal of Haematology · 1996 · 44 citations